Founded in Paris in 1920, Gide is a leading international law firm with 12 offices spread throughout the world.
Gide is physically present in six regions of the world, with 11 offices, enabling it to act on cases globally.
3 November 2021
Deals | France | USA | International Capital Markets
Gide has advised the banking syndicate composed of Goldman Sachs, Jefferies, Guggenheim Securities and Bryan, Garnier & Co. (the "underwriters") on the capital increase by Valneva reserved to a category of investors, for an estimated total gross amount of USD 102 million, after full exercise of the over-allotment clause, through an offering of American Depositary Shares (ADS) representing ordinary shares in the United States and a private placement in Europe of ordinary shares.
The ordinary shares are listed for trading on Euronext Paris and the ADSs are listed for trading on the Nasdaq Global Select Market.
Valneva is a specialty vaccine company focused on the development and marketing of prophylactic vaccines for infectious diseases with significant unmet medical needs, including Lyme disease, the Chikungunya virus, and Covid-19.
Gide also advised the underwriters on the initial public offering of Valneva on the Nasdaq Global Select Market in May 2021.
Gide advised the underwriters on French law aspects, with a team headed by partner Arnaud Duhamel and counsel Guilhem Richard, working with associates Mariléna Gryparis, Mélanie Simon-Giblin and Noëmie Mokalamba-Kabamba. The tax aspects were handled by counsel Alexandre Bochu.
The underwriters were advised by Goodwin Procter on US law aspects.
Valneva was represented by Cooley LLP on aspects of US law and by Hogan Lovells on aspects of French law.
